Primary Myelofibrosis — Trials

Primary Myelofibrosis — Trials · CancerIndex

Clinical trials

Registered studies

242 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 66
Recruiting: 36
Ph III recruiting: 2
Growth YoY: —
Industry share: 30%
Top sponsor: City of Hope Medical Center
Termination share: 38.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06468033	P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk	active not recruiting	Phase 3	160	PharmaEssentiaINDUSTRY	9	Aug 13, 2026	clinicaltrials
NCT04717414	An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions(INDEPENDENCE)	active not recruiting	Phase 3	313	CelgeneINDUSTRY	26